Icagen, Inc. 

NC

  SEC # 1518520

        

Click to view...

Registrant

About

Filings

Files

Relationships

Names

Topics

Web

Registrant
 SEC-Registered:  4/19/11   —   First EDGAR Filing:  5/18/11   –   Last Filing:  4/22/20  (None in the Past Year) 

Possible Termination of Registration and/or Duty to File Reports per 4/22/20 Form 15

Business Address      On:  4/22/20       [ Map ]		Mailing Address      On:  4/22/20       [ Map ]
4222 Emperor Blvd., Suite 350 Research Triangle Park Durham, North Carolina  27703 U.S.A.

Phone #		Organized In		Fiscal-Year End		IRS #		SEC CIK		SEC File #
+1 919-941-5206		Delaware, U.S.A.		12/31/yy		20-0982060		0001518520		000-54748

Industry Classification
SIC:     Code      U.S. Industry      Through      Source      Filings-Review Office 8731 Commercial Physical and Biological Research 2020 SEC Office of Industrial Applications & Services

        

Management
Director   In   NY   Taglich Michael N 2013-2019   CA   Roffman Edward 2012-2018   FL   Kabatznik Clive 2013-2018   NM   Palmieri Vincent 2013-2018   CA   Tyson Timothy 2014-2018   NY   Taglich Robert 2018   NM   Warner Benjamin 2012-2015 ↓List Pre-2015 Directors				Officer  Since  Most-Recent Title   In   NC   Krafte Douglas 2016 Chief Scientific Officer 2019   MA   Cunningham, Richard Anthony 2014 Chief Executive Officer 2019   FL   Korb Mark John 2013 Chief Financial Officer 2018   NM   Warner Benjamin 2012 Chief Scientific Officer 2015 ↓List Pre-2015 Officers